Primary Care Clinics in Westbrook, ME Accepting Medicare
7 Primary Care Clinics found. Showing 1 - 7
 Woodfords Family Services Clinic/Center Medicare: Not Enrolled in Medicare Practice Location: 15 Saunders Way, 720, Westbrook, ME 04092 Phone: 207-878-9663 Fax: 207-797-6137 |
Maine Medical Partners Westbrook Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Harnois Ave, Westbrook, ME 04092 Phone: 207-662-3400 Fax: 207-662-3401 |
Visavis Health Care Medical Group Of Me Pllc Family Medicine Medicare: Medicare Enrolled Practice Location: 300 Spring St, Westbrook, ME 04092 Phone: 929-491-7333 |
Maine Medical Partners Westbrook Family Medicine Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Harnois Ave, Westbrook, ME 04092 Phone: 207-662-3400 Fax: 207-662-3401 |
Maine Center For Endoscopy Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 2 Chabot St, Westbrook, ME 04092 Phone: 207-857-9311 Fax: 207-857-9324 |
Maine Centers For Healthcare Pa Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2 Chabot St, Westbrook, ME 04092 Phone: 207-857-9311 Fax: 207-857-9324 |
Landmark Medical Of Tennessee Pc General Practice Medicare: Medicare Enrolled Practice Location: 506 Main St, Westbrook, ME 04092 Phone: 572-372-4506 |
News Archive
HDAC inhibitors may help regulate alcoholism-induced anxiety
Epigenetics is the study of changes in organisms caused by modifying gene expression - by alcohol, for example - rather than alteration of the genetic code itself. Recent evidence suggests that alcohol can inhibit activity of an enzyme called histone deacetylase (HDAC) in the amygdala, a brain region that is crucial for storing memories and regulating fear, anxiety, and other emotions.
Quinnova Pharmaceuticals raises $17.4 million through Series B financing
Safeguard Scientifics, Inc., a holding company that builds value in growth-stage life sciences and technology companies, today announced it led a $17.4 million Series B financing round for Quinnova Pharmaceuticals, Inc., with participation from existing investors Thomas, McNerney & Partners and H.I.G. BioVentures.
MRCT announces licensing deal for development of novel therapy for inflammatory and immune diseases
Georg-August-University Gottingen, University of Regensburg and MRC Technology (MRCT) have signed exclusive license agreements through MBM ScienceBridge GmbH and in agreement with Bayerische Patentallianz GmbH, for the development of a novel therapy of inflammatory and immune diseases based on the depletion of inflammatory monocytes. The first targets will be rheumatoid arthritis (RA) and multiple sclerosis (MS).
Alcohol linked to 25% increase in liver disease deaths
The first report from the fledgling National End of Life Care Intelligence Network warns that the victims of liver disease are getting younger, with deaths increasing among people in their forties. Deaths rose from 9,231 in 2001 to 11,575 in 2009; some 60% of these were men, and 90% of them were under 70. Deaths are more common in England's northern regions marked by high unemployment and low educational achievement.
› Verified 3 days ago